⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
globenewswire.com
BIIB
New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
prnewswire.com
BIIB
Thryv Therapeutics Strengthens Senior Leadership Team with Appointment of Matt Killeen, PhD, as Chief Business Officer
prnewswire.com
BMN
RPH
RNOV
BIIB
My Green Lab Report Finds Biotech and Pharma Operations on a 1.5-Degree Path As Supply Chains Keep Sector Near 2 Degrees Celsius
accessnewswire.com
AZN
BIIB
IQV
Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial
globenewswire.com
NVS
BIIB
Alzheimer’s Therapeutics Market Size Projected to Reach $13.42 Billion by 2032 with a CAGR of 15.14% - SNS Insider
globenewswire.com
LILY
BIIB
COR
Stoke Therapeutics and Biogen Announce Presentations at the 2025 American Epilepsy Society Annual Meeting
businesswire.com
STOK
BIIB
Biogen and Stoke Therapeutics Announce Presentations at the 2025 American Epilepsy Society Annual Meeting
globenewswire.com
BIIB
STOK
Virtualware to strengthen its Board with two new independent directors, reinforcing the company’s governance and long-term strategy
globenewswire.com
GEV
BIIB
Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan
globenewswire.com
BIIB